✦ LIBER ✦

Individualized chemotherapy for women with recurrent ovarian cancer: is there a survival benefit?

✍ Scribed by Vera Loizzi; John K. Chan; Kathryn Osann; Fabio Capuccini; Philip J. DiSaia; Michael L. Berman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy for ovarian cancer: Is ther

✍ Eve Wiltshaw 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Survival Benefit of Hyperthermic Intrape

✍ Le Brun, Jean-François; Campion, Loic; Berton-Rigaud, Dominique; Lorimier, Gérar 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 332 KB

A prognostic nomogram to predict overall

✍ Previs, R.A.; Bevis, K.S.; Huh, W.; Tillmanns, T.; Perry, L.; Moore, K.; Chapman 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 536 KB

Is there a role for second-line chemothe

✍ Kevin B. Knonf 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Hormonotherapy with goserelin depot afte

✍ A. De Matteis; D. Montedoro; F. Nuzzo; G. Landi; V. Labonia; E. Rossi; G. D'Aiut 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Is there a possible survival benefit to

✍ M Aapro; E Bajetta; M Freund; T.J Littlewood; J.W.R Nortier; B Rapoport 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 352 KB